" #Sanders said CMS officials' preliminary decision Tuesday to restrict coverage of Biogen's Aduhelm to patients taking part in approved clinical trials was "an important step forward." CMS' final decision on the drug is expected by April." https://www.commondreams.org/news/2022/01/12/sanders-demands-refunds-seniors-hit-medicare-premium-hike